[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cancer Therapeutics & Biotherapeutic Market to Gain Traction, Predicts Allied Market Research in Its Report Recently Added at MarketPublishers.com

19 Aug 2016 • by Natalie Aster

LONDON – Nowadays, cancer is amid top causes of death worldwide. The most common kinds of cancer (resulting in death) include lung, stomach, liver, colorectal, oesophageal and breast cancers. Along with the mature chemotherapy market, a new approach for cancer treatment has emerged – biotherapy. Biotherapy boosts the immune system to stop or slow growth of cancer cells.

Constantly increasing demand for personalised medicine together with introduction of new approaches is predicted to drive the global cancer therapeutics and biotherapeutic market growth in the upcoming years.

Biogen IDEC, Astra Zeneca PLC, Merck, Bristol-Myers Squibb, Sanofi, Schering-Plough, Roche and Johnson & Johnson are amid top players in the worldwide market for cancer therapeutics and biotherapeutic.

The topical report “World Cancer Therapeutics and Biotherapeutic Market - Opportunities and Forecasts, 2014 - 2022” prepared by Allied Market Research offers an all-round analysis of the cancer therapeutics and biotherapeutic market and provides and in-depth market assessment on the basis of technology and geography. It discloses important information (both qualitative and quantitative) on the historical, current and forecast market performance, discusses the major market growth influencing factors, points out key growth opportunities and examines the merging challenges. The publication contains a detailed market trends analysis, explores the competitive scenario and contains details on top players. Forecasts through 2020 are also provided.

More reports by this publisher are offered at Allied Market Research page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest